Our results support the heterogeneity of the KP within the GBM landscape; furthermore, in the cell lines tested, KMO is enzymatically active, and thus, tryptophan catabolism in GBM cells could lead to the formation of both KP metabolite immunoregulators and NAD+. This evidence concerns the gene NPPA and glioblastoma.